Problems Continue with 340B Program

Citizens Against Government Waste has been critical of the 340B drug discount program for several years and has called for it be reformed.  On Thursday, October 8, the Berkeley Research Group (BRG) released a report that demonstrates once again how 340B has been corrupted and is being abused due to unclear legislation, legally questionable guidance, and unwarranted expansion.  The opening statement in the report, “For-Profit Pharmacy Participation in the 340B Program,” could not be better said:   “What started as a well-intentioned effort to provide safety-net providers free or discounted drugs to treat uninsured and vulnerable patients appears to have evolved into a profit-centric corporate initiative that has fundamentally altered the 340B program.”

Continue reading on CAGW.